Propolis Supplementation Reduces NLR, MPV, and FPG in Obese Individuals with Type 2 Diabetes Mellitus
Molecular and Cellular Biomedical Sciences · 2026-11-02 · 10 (3) · 158
DOI: 10.21705/mcbs.v10i3.800 ↗Abstract
Background: Obesity is associated with chronic inflammation and metabolic disorders, including Type 2 Diabetes Mellitus (T2DM). Biomarkers such as Interleukin-1β (IL-1β), Neutrophil-to-Lymphocyte Ratio (NLR), Mean Platelet Volume (MPV), and Fasting Plasma Glucose (FPG) are commonly used to assess inflammation and metabolic status. Propolis has demonstrated anti-inflammatory effects, however evidence in obese individuals with and without T2DM remains limited. This study evaluated the effects of propolis supplementation on these biomarkers.Materials and methods: A total of 45 obese adults aged
EUVIMED